Skip to main content
Erschienen in: Inflammation 4/2023

20.03.2023 | ORIGINAL ARTICLE

Identification of CCL20 as a Key Biomarker of Inflammatory Responses in the Pathogenesis of Intracerebral Hemorrhage

verfasst von: Zong-Qing Zheng, Gui-Qiang Yuan, Guo-Guo Zhang, Yan-Ting Chen, Qian-Qian Nie, Zhong Wang

Erschienen in: Inflammation | Ausgabe 4/2023

Einloggen, um Zugang zu erhalten

Abstract

Inflammatory responses after intracerebral hemorrhage (ICH) contribute to severe secondary brain injury, leading to poor clinical outcomes. However, the responsible genes for effective anti-inflammation treatment in ICH remain poorly elucidated. The differentially expressed genes (DEGs) of human ICH were explored by online GEO2R. Go and KEGG were used to explore the biological function of DEGs. Protein–protein interactions (PPI) were built in the String database. Critical modules of PPI were identified by a molecular complex detection algorithm (MCODE). Cytohubba was used to determine the hub genes. The mRNA-miRNA interaction network was built in the miRWalk database. The rat ICH model was applied to validate the key genes. A total of 776 DEGs were identified in ICH. Go and KEGG analyses indicated that DEGs were mainly involved in neutrophil activation and the TNF signaling pathway. GSEA analysis presented that DEGs were significantly enriched in TNF signaling and inflammatory response. PPI network was constructed in the 48 differentially expressed inflammatory response-related genes. The critical module of the PPI network was constructed by 7 MCODE genes and functioned as the inflammatory response. The top 10 hub genes with the highest degrees were identified in the inflammatory response after ICH. CCL20 was confirmed as a key gene and mainly expressed in neurons in the rat ICH model. The regulatory network between CCL20 and miR-766 was built, and the miR-766 decrease was confirmed in a human ICH dataset. CCL20 is a key biomarker of inflammatory response after intracerebral hemorrhage, providing a potential target for inflammatory intervention in ICH.
Literatur
1.
Zurück zum Zitat Zia, E. et al. 2007. Blood pressure in relation to the incidence of cerebral infarction and intracerebral hemorrhage. Hypertensive hemorrhage: debated nomenclature is still relevant. Stroke 38(10): 2681–5. Zia, E. et al. 2007. Blood pressure in relation to the incidence of cerebral infarction and intracerebral hemorrhage. Hypertensive hemorrhage: debated nomenclature is still relevant. Stroke 38(10): 2681–5.
2.
Zurück zum Zitat Keep, R.F., Y. Hua, and G. Xi. 2012. Intracerebral haemorrhage: Mechanisms of injury and therapeutic targets. Lancet Neurology 11 (8): 720–731.CrossRefPubMed Keep, R.F., Y. Hua, and G. Xi. 2012. Intracerebral haemorrhage: Mechanisms of injury and therapeutic targets. Lancet Neurology 11 (8): 720–731.CrossRefPubMed
3.
Zurück zum Zitat Xue, M., and V.W. Yong. 2020. Neuroinflammation in intracerebral haemorrhage: Immunotherapies with potential for translation. Lancet Neurology 19 (12): 1023–1032.CrossRefPubMed Xue, M., and V.W. Yong. 2020. Neuroinflammation in intracerebral haemorrhage: Immunotherapies with potential for translation. Lancet Neurology 19 (12): 1023–1032.CrossRefPubMed
4.
Zurück zum Zitat Gross, B.A., B.T. Jankowitz, and R.M. Friedlander. 2019. Cerebral Intraparenchymal hemorrhage: A review. JAMA 321 (13): 1295–1303.CrossRefPubMed Gross, B.A., B.T. Jankowitz, and R.M. Friedlander. 2019. Cerebral Intraparenchymal hemorrhage: A review. JAMA 321 (13): 1295–1303.CrossRefPubMed
6.
7.
Zurück zum Zitat Guo, Y. et al. 2022. Mechanism and regulation of microglia polarization in intracerebral hemorrhage. Molecules 27(20). Guo, Y. et al. 2022. Mechanism and regulation of microglia polarization in intracerebral hemorrhage. Molecules 27(20).
11.
Zurück zum Zitat Yuan, G., et al. 2023. Receptor-interacting protein 3-phosphorylated Ca(2+) /calmodulin-dependent protein kinase II and mixed lineage kinase domain-like protein mediate intracerebral hemorrhage-induced neuronal necroptosis. Journal of Neurochemistry 164 (1): 94–114.CrossRefPubMed Yuan, G., et al. 2023. Receptor-interacting protein 3-phosphorylated Ca(2+) /calmodulin-dependent protein kinase II and mixed lineage kinase domain-like protein mediate intracerebral hemorrhage-induced neuronal necroptosis. Journal of Neurochemistry 164 (1): 94–114.CrossRefPubMed
12.
Zurück zum Zitat Yu, G., et al. 2012. clusterProfiler: An R package for comparing biological themes among gene clusters. OMICS: A Journal of Integrative Biology 16 (5): 284–287.CrossRefPubMed Yu, G., et al. 2012. clusterProfiler: An R package for comparing biological themes among gene clusters. OMICS: A Journal of Integrative Biology 16 (5): 284–287.CrossRefPubMed
13.
Zurück zum Zitat Bader, G.D., and C.W. Hogue. 2003. An automated method for finding molecular complexes in large protein interaction networks. BMC Bioinformatics 4: 2.CrossRefPubMedPubMedCentral Bader, G.D., and C.W. Hogue. 2003. An automated method for finding molecular complexes in large protein interaction networks. BMC Bioinformatics 4: 2.CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Chin, C.H., et al. 2014. cytoHubba: identifying hub objects and sub-networks from complex interactome. BMC System Biology 8(Suppl 4): S11. Chin, C.H., et al. 2014. cytoHubba: identifying hub objects and sub-networks from complex interactome. BMC System Biology 8(Suppl 4): S11.
15.
Zurück zum Zitat Dweep, H., et al. 2011. miRWalk–database: Prediction of possible miRNA binding sites by “walking” the genes of three genomes. Journal of Biomedical Informatics 44 (5): 839–847.CrossRefPubMed Dweep, H., et al. 2011. miRWalk–database: Prediction of possible miRNA binding sites by “walking” the genes of three genomes. Journal of Biomedical Informatics 44 (5): 839–847.CrossRefPubMed
16.
Zurück zum Zitat Takaoka, Y., et al. 2016. Retinoic acid receptor agonist Am 80 inhibits CXCL2 production from microglial BV-2 cells via attenuation of NF-κB signaling. International Immunopharmacology 38: 367–376.CrossRefPubMed Takaoka, Y., et al. 2016. Retinoic acid receptor agonist Am 80 inhibits CXCL2 production from microglial BV-2 cells via attenuation of NF-κB signaling. International Immunopharmacology 38: 367–376.CrossRefPubMed
17.
Zurück zum Zitat Zhu, H., et al. 2019. Role and mechanisms of cytokines in the secondary brain injury after intracerebral hemorrhage. Progress in Neurobiology 178: 101610.CrossRefPubMed Zhu, H., et al. 2019. Role and mechanisms of cytokines in the secondary brain injury after intracerebral hemorrhage. Progress in Neurobiology 178: 101610.CrossRefPubMed
18.
Zurück zum Zitat Ziai, W.C., et al. 2021. Early inflammatory cytokine expression in cerebrospinal fluid of patients with spontaneous intraventricular hemorrhage. Biomolecules 11(8). Ziai, W.C., et al. 2021. Early inflammatory cytokine expression in cerebrospinal fluid of patients with spontaneous intraventricular hemorrhage. Biomolecules 11(8).
19.
Zurück zum Zitat Landreneau, M.J., et al. 2018. CCL2 and CXCL10 are associated with poor outcome after intracerebral hemorrhage. Annals of Clinical Translational Neurology 5 (8): 962–970.CrossRefPubMedPubMedCentral Landreneau, M.J., et al. 2018. CCL2 and CXCL10 are associated with poor outcome after intracerebral hemorrhage. Annals of Clinical Translational Neurology 5 (8): 962–970.CrossRefPubMedPubMedCentral
20.
Zurück zum Zitat Leasure, A.C., et al. 2021. Association of serum IL-6 (interleukin 6) with functional outcome after intracerebral hemorrhage. Stroke 52 (5): 1733–1740.CrossRefPubMedPubMedCentral Leasure, A.C., et al. 2021. Association of serum IL-6 (interleukin 6) with functional outcome after intracerebral hemorrhage. Stroke 52 (5): 1733–1740.CrossRefPubMedPubMedCentral
21.
Zurück zum Zitat Guo, F., et al. 2020. Chemokine CCL2 contributes to BBB disruption via the p38 MAPK signaling pathway following acute intracerebral hemorrhage. The FASEB Journal 34 (1): 1872–1884.CrossRefPubMed Guo, F., et al. 2020. Chemokine CCL2 contributes to BBB disruption via the p38 MAPK signaling pathway following acute intracerebral hemorrhage. The FASEB Journal 34 (1): 1872–1884.CrossRefPubMed
22.
Zurück zum Zitat Xu, D., et al. 2021. Sphingosine-1-phosphate receptor 3 is implicated in BBB injury via the CCL2-CCR2 axis following acute intracerebral hemorrhage. CNS Neuroscience & Therapeutics 27 (6): 674–686.CrossRef Xu, D., et al. 2021. Sphingosine-1-phosphate receptor 3 is implicated in BBB injury via the CCL2-CCR2 axis following acute intracerebral hemorrhage. CNS Neuroscience & Therapeutics 27 (6): 674–686.CrossRef
23.
Zurück zum Zitat Yan, J., et al. 2020. CCR1 Activation promotes neuroinflammation through CCR1/TPR1/ERK1/2 signaling pathway after intracerebral hemorrhage in mice. Neurotherapeutics 17 (3): 1170–1183.CrossRefPubMedPubMedCentral Yan, J., et al. 2020. CCR1 Activation promotes neuroinflammation through CCR1/TPR1/ERK1/2 signaling pathway after intracerebral hemorrhage in mice. Neurotherapeutics 17 (3): 1170–1183.CrossRefPubMedPubMedCentral
24.
Zurück zum Zitat Yan, J., et al. 2022. Met-RANTES preserves the blood-brain barrier through inhibiting CCR1/SRC/Rac1 pathway after intracerebral hemorrhage in mice. Fluids Barriers CNS 19 (1): 7.CrossRefPubMedPubMedCentral Yan, J., et al. 2022. Met-RANTES preserves the blood-brain barrier through inhibiting CCR1/SRC/Rac1 pathway after intracerebral hemorrhage in mice. Fluids Barriers CNS 19 (1): 7.CrossRefPubMedPubMedCentral
25.
Zurück zum Zitat Walsh, K.B., et al. 2019. Intracerebral hemorrhage induces monocyte-related gene expression within six hours: Global transcriptional profiling in swine ICH. Metabolic Brain Disease 34 (3): 763–774.CrossRefPubMedPubMedCentral Walsh, K.B., et al. 2019. Intracerebral hemorrhage induces monocyte-related gene expression within six hours: Global transcriptional profiling in swine ICH. Metabolic Brain Disease 34 (3): 763–774.CrossRefPubMedPubMedCentral
26.
Zurück zum Zitat Schutyser, E., S. Struyf, and V. Damme. 2003. The CC chemokine CCL20 and its receptor CCR6. J Cytokine growth factor reviews 14 (5): 409–426.CrossRef Schutyser, E., S. Struyf, and V. Damme. 2003. The CC chemokine CCL20 and its receptor CCR6. J Cytokine growth factor reviews 14 (5): 409–426.CrossRef
27.
Zurück zum Zitat Ranasinghe, R. and R. Eri. 2018. Modulation of the CCR6-CCL20 axis: a potential therapeutic target in inflammation and cancer. Medicina (Kaunas) 54(5). Ranasinghe, R. and R. Eri. 2018. Modulation of the CCR6-CCL20 axis: a potential therapeutic target in inflammation and cancer. Medicina (Kaunas) 54(5).
28.
Zurück zum Zitat Meitei, H.T., N. Jadhav, and G. Lal. 2021. CCR6-CCL20 axis as a therapeutic target for autoimmune diseases. Autoimmunity Reviews 20 (7): 102846.CrossRefPubMed Meitei, H.T., N. Jadhav, and G. Lal. 2021. CCR6-CCL20 axis as a therapeutic target for autoimmune diseases. Autoimmunity Reviews 20 (7): 102846.CrossRefPubMed
29.
Zurück zum Zitat Hayakawa, K. et al. (2019) MicroRNA-766–3p contributes to anti-inflammatory responses through the indirect inhibition of NF-κB signaling. International Journal of Molecular Science 20(4). Hayakawa, K. et al. (2019) MicroRNA-766–3p contributes to anti-inflammatory responses through the indirect inhibition of NF-κB signaling. International Journal of Molecular Science 20(4).
Metadaten
Titel
Identification of CCL20 as a Key Biomarker of Inflammatory Responses in the Pathogenesis of Intracerebral Hemorrhage
verfasst von
Zong-Qing Zheng
Gui-Qiang Yuan
Guo-Guo Zhang
Yan-Ting Chen
Qian-Qian Nie
Zhong Wang
Publikationsdatum
20.03.2023
Verlag
Springer US
Erschienen in
Inflammation / Ausgabe 4/2023
Print ISSN: 0360-3997
Elektronische ISSN: 1573-2576
DOI
https://doi.org/10.1007/s10753-023-01807-4

Weitere Artikel der Ausgabe 4/2023

Inflammation 4/2023 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.